J. Pöss, F. Custodis, C. Werner, O. Weingärtner, and M. Böhm, Cardiovascular Disease and Dyslipidemia: Beyond LDL, Current Pharmaceutical Design, vol.17, issue.9, pp.861-870, 2011.
DOI : 10.2174/138161211795428858

E. Degoma, R. Degoma, and D. Rader, Beyond High-Density Lipoprotein Cholesterol Levels, Journal of the American College of Cardiology, vol.51, issue.23, pp.2199-2211, 2008.
DOI : 10.1016/j.jacc.2008.03.016

L. Martinez, S. Jacquet, J. Esteve, C. Rolland, E. Cabezon et al., Ectopic ??-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis, Nature, vol.269, issue.6918, pp.75-79, 2003.
DOI : 10.1074/jbc.M204996200

A. Fabre, C. Malaval, B. Addi, A. Verdier, C. Pons et al., P2Y13 receptor is critical for reverse cholesterol transport, Hepatology, vol.44, issue.4, pp.1477-1483, 2010.
DOI : 10.1002/hep.23897

N. Serhan, C. Cabou, C. Verdier, L. Lichtenstein, N. Malet et al., Chronic pharmacological activation of P2Y13 receptor in mice decreases HDL-cholesterol level by increasing hepatic HDL uptake and bile acid secretion, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1831, issue.4, pp.719-725, 2013.
DOI : 10.1016/j.bbalip.2012.12.006
URL : https://hal.archives-ouvertes.fr/inserm-01054874

R. Dullaart, W. Annema, J. De-boer, and U. Tietge, Pancreatic ??-cell function relates positively to HDL functionality in well-controlled Type 2 diabetes mellitus, Atherosclerosis, vol.222, issue.2, pp.567-573, 2012.
DOI : 10.1016/j.atherosclerosis.2012.03.037

N. Nijstad, J. De-boer, W. Lagor, M. Toelle, D. Usher et al., Overexpression of apolipoprotein O does not impact on plasma HDL levels or functionality in human apolipoprotein A-I transgenic mice, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1811, issue.4, pp.294-299, 2011.
DOI : 10.1016/j.bbalip.2011.01.008

B. Paigen, A. Morrow, P. Holmes, and D. Mitchell, Quantitative assessment of atherosclerotic lesions in mice, Atherosclerosis, vol.68, issue.3, pp.231-240, 1987.
DOI : 10.1016/0021-9150(87)90202-4

N. Nijstad, T. Gautier, F. Briand, D. Rader, and U. Tietge, Biliary Sterol Secretion Is Required for Functional In Vivo Reverse Cholesterol Transport in Mice, Gastroenterology, vol.140, issue.3, pp.1043-1051, 2011.
DOI : 10.1053/j.gastro.2010.11.055

S. Naik, X. Wang, D. Silva, J. , J. M. Macphee et al., Pharmacological Activation of Liver X Receptors Promotes Reverse Cholesterol Transport In Vivo, Circulation, vol.113, issue.1, pp.90-97, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.560177

S. Jacquet, C. Malaval, L. Martinez, K. Sak, C. Rolland et al., The nucleotide receptor P2Y13 is a key regulator of hepatic High-Density Lipoprotein (HDL) endocytosis, Cellular and Molecular Life Sciences, vol.62, issue.21, pp.2508-2515, 2005.
DOI : 10.1007/s00018-005-5194-0

B. François, U. Snehal, N. Llia, F. John, S. Millar et al., Both the Peroxisome Proliferator-Activated Receptor ? Agonist, GW0742, and Ezetimibe Promote Reverse Cholesterol Transport in Mice by Reducing Intestinal Reabsorption of HDL-Derived Cholesterol, Clin Transl Sci, vol.2, pp.127-133, 2009.

A. Dikkers, J. Freak-de-boer, W. Annema, A. Groen, and U. Tietge, Scavenger receptor BI and ABCG5/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice, Hepatology, vol.46, issue.Suppl, pp.293-303, 2013.
DOI : 10.1002/hep.26316

C. Röhrl, T. Pagler, A. Ellinger, and M. Pavelka, Characterization of endocytic compartments after holo-high density lipoprotein particle uptake in HepG2 cells, Histochemistry and Cell Biology, vol.20, issue.3, pp.261-272, 2011.
DOI : 10.1007/s00418-009-0672-3

M. Haghpassand, P. Bourassa, O. Francone, and R. Aiello, Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels, Journal of Clinical Investigation, vol.108, issue.9, pp.1315-1320, 2001.
DOI : 10.1172/JCI200112810

D. Communi, N. Gonzalez, M. Detheux, S. Brezillon, V. Lannoy et al., Identification of a Novel Human ADP Receptor Coupled to Gi, Journal of Biological Chemistry, vol.276, issue.44
DOI : 10.1074/jbc.M105912200

. Lichtenstein, Lack of P2Y13 in mice fed a high cholesterol diet results in decreased hepatic cholesterol content, biliary lipid secretion and reverse cholesterol transport, Nutrition & Metabolism, vol.10, issue.1, p.67, 2013.
DOI : 10.1074/jbc.M105912200
URL : https://hal.archives-ouvertes.fr/inserm-01055313